Charles River Labs Intl buy Barclays PLC
Start price
02.10.25
/
50%
€149.30
Target price
02.10.26
€166.12
Performance (%)
51.17%
Price
05.08.26
€225.70
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Charles River Labs Intl has seen massive gains of 51.17%. This prediction currently runs until 02.10.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Charles River Labs Intl | 9.990% | 9.990% |
| iShares Core DAX® | 3,15 % | 1,50 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % |
| iShares S&P 500 | 4,58 % | 1,92 % |
Comments by Barclays_PLC for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International (NYSE:CRL) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $195.00 price target on the stock, up previously from $165.00.
Ratings data for CRL provided by MarketBeat
Stopped prediction by Barclays_PLC for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€151.30
08.05.26
08.05.26
-
08.05.27
08.05.27
33.97%
05.08.26
05.08.26
Charles River Labs Intl
Start price
Target price
Perf. (%)
€149.35
06.11.25
06.11.25
€182.47
06.11.26
06.11.26
51.12%
05.08.26
05.08.26